Seelos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | Buy€92,069 | Raj Mehra | Individual | 75,757 | €1.22 | |
30 Nov 23 | Buy€91,894 | Michael Golembiewski | Individual | 83,000 | €1.11 |
Insider Trading Volume
Insider Buying: NXE insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,280 | 0.0386% |
Individual Insiders | 273,469 | 2% |
Institutions | 2,243,591 | 16.4% |
General Public | 11,158,237 | 81.6% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 283%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
463,851 | €354.9k | 0% | 1.37% | |||
303,714 | €232.4k | 913% | no data | |||
283,878 | €217.2k | 64.6% | no data | |||
264,754 | €202.6k | 0% | no data | |||
228,593 | €174.9k | 90.2% | 0.07% | |||
185,143 | €141.7k | 69.3% | no data | |||
181,259 | €138.7k | 775% | 0.04% | |||
111,615 | €85.4k | -50.4% | no data | |||
86,452 | €66.1k | 2,410% | no data | |||
70,163 | €53.7k | 323% | no data | |||
69,728 | €53.4k | 70.9% | no data | |||
55,964 | €42.8k | -0.89% | no data | |||
40,536 | €31.0k | 0% | no data | |||
40,000 | €30.6k | 0% | 0.19% | |||
30,010 | €23.0k | 499% | 0.01% | |||
29,343 | €22.5k | -27.4% | no data | |||
25,246 | €19.3k | 0% | no data | |||
12,948 | €9.9k | -1.26% | no data | |||
9,071 | €6.9k | -3.6% | no data | |||
8,581 | €6.6k | -59.7% | no data | |||
5,280 | €4.0k | 0% | no data | |||
5,000 | €3.8k | 384% | no data | |||
3,758 | €2.9k | 3,450% | no data | |||
2,015 | €1.5k | 98.5% | no data | |||
1,167 | €892.9 | 0% | no data |